Cytheris
 
IL-7 in HIV



Cytheris Scientific Publications/Abstracts/Posters -- Oncology

Cytheris 1

Sportès C, Hakim FT, Memon SA, Zhang H, Chua KS, Brown MR, Fleisher TA, Krumlauf MC, Babb RR, Chow CK, Fry TJ, Engels J, Buffet R, Morre M, Amato RJ, Venzon DJ, Korngold R, Pecora A, Gress RE, Mackall CL. Administration of rhIL-7 in Humans Increases in vivo TCR Repertoire Diversity by Preferential Expansion of Naïve T cell Subsets. 2008. J Exp Med. 205(6). View Abstract on PubMed

Rosenberg SA, Sportès C, Ahmadzadeh M, Fry TJ, Ngo LT, Schwarz SL, Stetler-Stevenson M, Morton KE, Mavroukakis SA, Morre M, Buffet R, Mackall CL, Gress RE. IL-7 Administration to Humans Leads to Expansion of CD8+ and CD4+ Cells but a Relative Decrease of CD4+ T-Regulatory Cells. 1997. J Immunother; 29: 313-19. View Abstract on PubMed


Sportes C, Krumlauf, M, Babb R, Foruraghi, L, Daub J, Avila D, Chow C, Zhang H, Chua K, Fry T, Memon S, Hakim F, Fleisher T, Brown M, Engle J, Buffet R, Morre M, Gress R, Mackall C. 2006.  IL-7 Administration in Humans Results in Preferential Expansion of Naïve and Memory CD4+ & CD8+ T-Cells with Relative Decrease in Regulatory T-Cells (T-Regs). 2006 American Society of Hematology Annual Meeting, Oral Session, Abstract #871. View Abstract

BACK

 

Home   About Cytheris   Science   Pipeline & Products   Clinical Trials   Business Development   News Room  Careers   Contact Us   
Sitemap   Privacy Policy   Terms of Use   © 2008 Cytheris, Inc. All rights reserved.